GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Forza Innovations Inc (OTCPK:FORZ) » Definitions » Sloan Ratio %

Forza Innovations (Forza Innovations) Sloan Ratio % : 0.00% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Forza Innovations Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Forza Innovations's Sloan Ratio for the quarter that ended in Dec. 2023 was 0.00%.

Warning Sign:

When sloan ratio (-4245.05)% higher than 25% or lower than -25%, earnings are more likely to be made up of accruals.

As of Dec. 2023, Forza Innovations has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Forza Innovations Sloan Ratio % Historical Data

The historical data trend for Forza Innovations's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Forza Innovations Sloan Ratio % Chart

Forza Innovations Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Sloan Ratio %
Get a 7-Day Free Trial -10.24 -10.26 -2,245.65 -413.17 -4,245.05

Forza Innovations Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Forza Innovations's Sloan Ratio %

For the Medical Devices subindustry, Forza Innovations's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Forza Innovations's Sloan Ratio % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Forza Innovations's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Forza Innovations's Sloan Ratio % falls into.



Forza Innovations Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Forza Innovations's Sloan Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Sloan Ratio=(Net Income (A: Jun. 2023 )-Cash Flow from Operations (A: Jun. 2023 )
-Cash Flow from Investing (A: Jun. 2023 ))/Total Assets (A: Jun. 2023 )
=(-4.756--0.764
--0.129)/0.091
=-4,245.05%

Forza Innovations's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(-2.824--0.218
--0.028)/0.073
=-3,531.51%

Forza Innovations's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was -1.079 (Mar. 2023 ) + -1.976 (Jun. 2023 ) + -0.648 (Sep. 2023 ) + 0.879 (Dec. 2023 ) = $-2.82 Mil.
Forza Innovations's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was -0.161 (Mar. 2023 ) + -0.043 (Jun. 2023 ) + 0 (Sep. 2023 ) + -0.014 (Dec. 2023 ) = $-0.22 Mil.
Forza Innovations's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was -0.028 (Mar. 2023 ) + 0 (Jun. 2023 ) + 0 (Sep. 2023 ) + 0 (Dec. 2023 ) = $-0.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Forza Innovations  (OTCPK:FORZ) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, Forza Innovations has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Forza Innovations Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Forza Innovations's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Forza Innovations (Forza Innovations) Business Description

Traded in Other Exchanges
N/A
Address
406 9th Avenue, Suite 210, San Diego, CA, USA, 92101
Forza Innovations Inc is in the health-tech wearable performance business. The company has acquired all the ownership and rights to certain late developmental-stage products, including the J4 Sport, J4 X, and J4 Fitbelt. These products are wearable back compression devices, used to relax, warm up, loosen, or relax stiff & sore muscles. The therapeutic application of heat causes a change in the temperature of the soft tissues which decreases joint stiffness and relieves inflammation.
Executives
Johnny Forzani director, 10 percent owner, officer: Pres., CEO, Sec., Treas., CFO 30 FORZANI WAY, CALGARY A0 T3Z 1L5
Shefali Vibhakar director, 10 percent owner, officer: President, CEO, CFO, Sec. Trea 1914 24TH AVE E, PALMETTO FL 34221
Tom Forzani director 30 FORZANI WAY, CALGARY A0 T3Z 1L5
Geoff Stanbury director BOX 25 SITE 1 RR1, MILLARVILLE A0 T0L 1K0